TICAROS Co., Ltd.: Clinical Trials

2 trials sponsored by TICAROS Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1
Phase 11Recruiting 1

Follow TICAROS Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma
TC011 single-arm - Follicular Lymphoma (FL)
Phase 2Not yet recruitingTICAROS Co., Ltd.402026-03-012026-01-22
Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
TC011 - Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma
Phase 1 / Phase 2RecruitingTICAROS Co., Ltd.982023-08-032026-03-16

Conditions studied

Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)

Countries

South Korea (1)

Top investigators

Won Seok Kim, MD, PhD (1)